Showing results (201-210 of 585) with videos related to
Sort By:
Pageof 59
The Journal of Laboratory and Clinical Medicine|July 1, 1984
Stable red cell mass despite contracted plasma volume in men with essential hypertensionI Kobrin, E D Frohlich, H O Ventura, et al.Clinical Pharmacology and Therapeutics|February 1, 1983
Hemodynamic effects of intravenous labetalol in essential hypertensionF G Dunn, W Oigman, F H Messerli, et al.The American Journal of Cardiology|March 1, 1983
Immediate hemodynamic effects of a new calcium-channel blocking agent (nitrendipine) in essential hypertensionH O Ventura, F H Messerli, W Oigman, et al.Schweizerische Medizinische Wochenschrift|December 10, 1977
[Increased renal prostaglandin E2 secretion in Bartter's syndrome]H A Schwarz, P Weidmann, F H Messerli, et al.Canadian Medical Association Journal|November 8, 1975
Arterial hypertension and neurofibromatosis: renal artery stenosis and coarctation of abdominal aortaW Schürch, F H Messerli, J Genest, et al.The American Journal of Medicine|March 11, 1988
Does the renin-angiotensin-aldosterone system modify cardiac structure and function in essential hypertension?R E Schmieder, F H Messerli, G E Garavaglia, et al.Annals of Internal Medicine|August 1, 1987
Disparate cardiovascular findings in men and women with essential hypertensionF H Messerli, G E Garavaglia, R E Schmieder, et al.Archives of Internal Medicine|March 1, 1984
Clinical and hemodynamic determinants of left ventricular dimensionsF H Messerli, K Sundgaard-Riise, H O Ventura, et al.The American Journal of Cardiology|May 1, 1981
Echocardiographic diastolic ventricular abnormality in hypertensive heart disease: atrial emptying indexG R Dreslinski, E D Frohlich, F G Dunn, et al.Journal of Physiology and Pharmacology : an Official Journal of the Polish Physiological Society|May 28, 2023
Urocortin 2 - a protective effect in hypertension?A Dzieza-Grudnik, O Siga, J Walczewska, et al.Pageof 59